4TH ANNUAL BREAST CANCER SYMPOSIUM
LIVE IN PERSON AND ONLINE BROADCAST
The 3rd Annual Breast Cancer Symposium: The Seasons of Breast Cancer is being organized in collaboration with New York Oncology Hematology (NYOH), The University of Chicago Pritzker School of Medicine, and myMedEd, Inc. With an expanded agenda, this accredited conference offers 18.5 continuing education credits.
The 3rd Annual Breast Cancer Symposium was held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A discussions. The conference is being offered on-demand until October 30th.
Breast cancer is a multifaceted disease and the second most common cancer among women in the United States. Advances in the ability to tailor an individual patient’s diagnosis, management, and treatment have been growing exponentially during the last twenty years. The identification of novel therapeutic strategies has also led to improved surgical and radiation outcomes. Actionable targets have identified smarter systemic therapies with improved, disease-free, overall survival benefits. In addition to awareness, addressing the health, emotional, and physical well-being of patients after breast cancer treatment has improved the overall quality of life for the patient and their families. The goal of this conference is to educate the medical and global community and foster communication that will benefit the individual patient as well as the community.
Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.
After completing this activity, participants will be able to:
- Review the modern surgical approaches addressed in the patient encounter
- Discuss updates in breast cancer imaging for earlier detection
- Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing and triple negative breast cancer
- Review advances in radiation therapy and outcomes
- Identify risk factors and endocrine interventions in patients high risk for developing breast cancer
- Discuss the role of hereditary genetics and the implication to the patient and their families
This Activity Is Planned By myMedEd, Inc.